Dilaudid
NDC 76045-121, Hydromorphone hydrochloride, injection, solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 76045-121
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA019034
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/76045-121 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDROMORPHONE HYDROCHLORIDE.2 mg/mL
Pharmacologic classes
Full Opioid Agonists [MoA]; Opioid Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76045-121-11 | 76045012111 | 10 SYRINGE in 1 CARTON (76045-121-11) / 1 mL in 1 SYRINGE (76045-121-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/9eebd88a-5632-460f-b7b6-26c8a180540dMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=76045-121
Use it
Look up 76045-121 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76045-121 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76045-121. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.